Vimta Labs Ltd

NSE: VIMTALABS · BSE: 524394 · Healthcare · 9 announcements

Share price: ₹599.30
Market cap: ₹2,679 Cr
Revenue (annual): ₹407.3 Cr
Net profit (annual): ₹77.51 Cr
P/E (TTM): 33.6×Sector 57.8×
Promoter holding: 35.67%-0.18% QoQ
FII holding: 4.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Financial Results 1 Employee Stock Options 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 18:08 IST NSE

Earnings Call

Vimta Labs Investor Presentation: Key Takeaways

Vimta Labs reported Q1 FY27 total income of INR 1,129 million, up 13.7% YoY. Strategy focuses on diversifying into Biologics (CRAD) and strengthening domestic food testing.

Call: Guides 25% growth

Open call summary → Read the filing ↗

20 Jul 2026 15:19 IST BSE

Earnings Call

Vimta Labs Earnings Call: Key Takeaways

Vimta Labs reports 13.7% YoY revenue growth in Q1 FY27, driven by strong performance in Pharma and Food testing segments with a 36.4% EBITDA margin.

Open call summary → Read the filing ↗